BUSINESS● LOWAug 14 · Aug 14, 2026, 11:03 AM
Tvardi Therapeutics GAAP EPS of -$0.69 misses by $0.06
Seeking Alpha Tech
Tvardi Therapeutics reported a GAAP EPS of -$0.69, which missed expectations by $0.06. This indicates the company's financial performance did not meet analysts' projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS43m agoGold market consolidating rather than entering bear market, Metals Focus analyst saysSeeking Alpha TechBUSINESS44m agoCollegium resolves Nucynta patent dispute with GrünenthalSeeking Alpha Tech